School of Medicine
Showing 1-100 of 928 Results
-
Angelle Desiree LaBeaud
Professor of Pediatrics (Infectious Diseases), Senior Fellow at the Woods Institute for the Environment and Professor, by courtesy, of Epidemiology and Population Health and at the Stanford Doerr School of Sustainability
Current Research and Scholarly InterestsArthropod-borne viruses are emerging and re-emerging infections that are spreading throughout the world. Our laboratory investigates the epidemiology of arboviral infections, focusing on the burden of disease and the long-term complications on human health. In particular, Dr. LaBeaud investigates dengue, chikungunya, and Rift Valley fever viruses in Kenya, where outbreaks cause fever, arthritis, retinitis, encephalitis, and hemorrhagic fever. Our main research questions focus on the risk factors for arboviral infections, the development of diagnostic tests that can be administered in the field to quickly determine what kind of arboviral infection a person has, and the genetic and immunologic investigation of why different people respond differently to the same infection. Our long-term goals are to contribute to a deeper understanding of arboviral infections and their long-term health consequences and to optimize control strategies to prevent these emerging infections. Our laboratory also investigates the effects of antenatal and postnatal parasitic infections on vaccine responses, growth, and development of Kenyan children.
My lab at Stanford supports the field work that is ongoing in Kenya, but we also have several projects that are based locally. We strive to improve diagnostics of arboviral infections and are using Luminex technology to build a new screening assay. We also have created a Luminex based platform to assess vaccine responses against multiple pathogens. -
Norman J. Lacayo, MD
Associate Professor of Pediatrics (Hematology and Oncology)
Current Research and Scholarly InterestsPediatric Hematology/Oncology, Phase I drug studies for refractory and relapsed leukemia; genomic studies, biologic risk-stratification and treatment of acute myeloid leukemia; prediction or induction response and risk of relapse using phosphoproteomics in childhood AML; novel MRD techniques in childhood ALL.
-
Uri Ladabaum
Professor of Medicine (Gastroenterology and Hepatology)
Current Research and Scholarly InterestsGastrointestinal cancer prevention and risk management. Risk stratification. Cost-effectiveness analysis. Health services research.
-
Amy Ladd, MD
Elsbach-Richards Professor of Surgery and Professor, by courtesy, of Medicine (Immunology & Rheumatology) and of Surgery (Plastic and Reconstructive Surgery)
Current Research and Scholarly InterestsResearch Interests
1. The kinematics and forces associated with thumb carpometcarpal (CMC) function and pathology
2. The anatomy, microstructure, and immunofluorescent characteristics of the thumb CMC joint
3. Pathomechaniics of CMC arthritis: biomechanical wear, injury, genetic, and environmental causes
4. Biomechanics of the golf swing
5. Archiving, vitalizing, and innovating medical and surgical knowledge, most recently with innovative iBook monographs -
Richard Lafayette
Professor of Medicine (Nephrology)
Current Research and Scholarly InterestsWe are continuing to grow a glomerulonephritis cohort study, including immunologic characterization. We have completed interventional studies of preeclampsia exploring the nitric oxide, endothelin system and effects on glomerular function and morphometry. We continue to recruit patients for treatment and observational studies of glomerular disease, including FSGS, membranous and particularly IgA nephropathy. We also are actively studying renal disease in systemic amyloidosis.
-
Teresa LaFromboise
Professor of Education
Current Research and Scholarly InterestsBicultural competence and resilience in ethnic minority adolescent development. Particularly, the influence of enculturation and acculturation experiences on adolescent development. Cultural considerations in individual, school and community-based psychological interventions with adolescents and emerging adults.
-
Mauro Lago Docampo
Postdoctoral Scholar, Cardiology
Current Research and Scholarly InterestsI have always been fascinated by the process of genetic penetrance, how two people can carry the same mutation but only one of them may be affected.
My main project focuses on understanding the role of TBX4 in the development of Pulmonary Arterial Hypertension (PAH). Mutations in this gene are related to very different diseases. In my research, I mix cellular models, gene editing, and high throughput assays to find the determinants of penetrance in the development of PAH under these conditions. -
Sheila Lahijani, MD, FACLP
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
BioAfter graduating from Brown Medical School, Dr. Lahijani completed the Combined Internal Medicine/Psychiatry Residency Program at Rush University Medical Center in Chicago. She then served as a physician in the areas of primary care and triple diagnosis (addiction, HIV, mental health). Thereafter, Dr. Lahijani completed the Psychosomatic Medicine Fellowship at the Feinberg School of Medicine of Northwestern University where she worked at the Lurie Comprehensive Cancer Center. During her fellowship, she also served as a psychiatric oncologist at Memorial Sloan Kettering Cancer Center.
Dr. Lahijani joined the faculty of Stanford University School of Medicine in 2015 as a Clinical Assistant Professor of Psychiatry and Behavioral Sciences. Since her initial appointment, Dr. Lahijani has served as the lead psychiatric oncologist at the Stanford Cancer Center where she provides psychiatric consultation services to patients with cancer and collaborates closely with her hematology and oncology colleagues to deliver comprehensive cancer care.
In 2019, she was appointed as the Medical Director of the Stanford Cancer Center Psychosocial Oncology Program where she works in Stanford Cancer Center leadership and oversees the development and operationalization of psychiatric consultation for patients with cancer. Dr. Lahijani also attends on the medical/surgical units, ICUs and in the emergency department at Stanford Hospital and Clinics to provide care for patients with complex medical and psychiatric diagnoses and to teach psychiatry, internal medicine, and neurology trainees. Dr. Lahijani is trained in and administers several psychotherapeutic modalities, including Meaning Centered Psychotherapy and Dignity Therapy, in addition to practicing psychopharmacology.
As Faculty of the Advancing Communication Excellence at Stanford, Dr. Lahijani leads foundational workshops for faculty and staff to advance communication skills with patients, families, and their colleagues. She is committed to developing and contributing to efforts that focus on relationship centered skills and provider wellness.
Her clinical and scholarly interests include the interface of medicine and psychiatry, pharmacology, psycho-oncology, collaborative care models, psychotherapy for the medically ill, interdisciplinary medical education, teaching, and writing. -
Christine Shyrue Lai
Affiliate, Department Funds
Fellow in Pediatrics - Hematology/OncologyBioDr. Christine Lai is a Pediatric Hematology Oncology Fellow in the Bass Center at Lucile Packard Children's Hospital. Prior to coming to Stanford, she trained in pediatric residency at Northwell Alexandra Cohen Children's Hospital in New Hyde Park, NY and attended medical school at New York University. Her current research interests are cancer immunotherapy and cancer glycobiology. She currently works in Professor Carolyn Bertozzi's lab and sees patients in the Bass Center Clinic.
-
David D. Laitin
James T. Watkins IV and Elise V. Watkins Professor
BioDavid D. Laitin is the James T. Watkins IV and Elise V. Watkins Professor of Political Science at Stanford University. He received his BA from Swarthmore College, and then served as a Peace Corps Volunteer in Somalia and Grenada, where he became national tennis champion in 1970. Back in the US, he received his Ph.D. in political science from UC Berkeley, working under the direction of Ernst Haas and Hanna Pitkin.
He has taught at three great universities: UCSD (1975-87), the University of Chicago (1987-1999) and now at Stanford. Over his career, as a student of comparative politics, he has conducted field research in Somalia, Yorubaland (Nigeria), Catalonia (Spain), Estonia, and France, all the time focusing on issues of language and religion, and how these cultural phenomena link nation to state. His books include Politics, Language and Thought: The Somali Experience (1977), Hegemony and Culture: Politics and Religious Change among the Yoruba (1986), Language Repertoires and State Construction in Africa (1992), Identity in Formation: The Russian-Speaking Populations in the Near Abroad (1998); Nations, States and Violence (2007); Why Muslim Integration Fails in Christian-Heritage Societies (2016); and African Politics Since Independence (2019).
In collaboration with James Fearon, he has published several papers on ethnicity, ethnic cooperation, the sources of civil war, and on policies that work to settle civil wars. Laitin has also collaborated with Alan Krueger on international terrorism and with Eli Berman on suicide terrorism.
In 2008-2009, with support from the National Science Foundation, and with a visiting appointment at Sciences-Po Paris, Laitin conducted ethnographic, survey and experimental research on Muslim integration into France, seeking to assess the magnitude of religious discrimination and isolate the mechanisms that sustain it. In collaboration with Claire Adida and Marie-Anne Valfort, they published the results in Why Muslim Integration Fails in Christian Heritage Societies (Harvard Press, 2016).
In 2016, Laitin became co-director of Stanford's Immigration Policy Lab, and has co-authored several papers published in "Science", "Proceedings of the National Academy of Sciences" and "Nature Human Behavior" that estimate the effects of policy on immigrant integration.
Laitin has been a recipient of fellowships from the Howard Foundation, the Rockefeller Foundation, the Guggenheim Foundation, and the Russell Sage Foundation. He is an elected member of the American Academy of Arts and Sciences and the National Academy of Sciences. In 2021 Laitin was the recipient of the John Skytte Prize in Political Science from the Johan Skytte Foundation in Uppsala University, Sweden. -
Rayhan A. Lal, MD
Assistant Professor of Medicine (Endocrinology) and of Pediatrics (Endocrinology)
BioI grew up in the east bay area and have had type 1 diabetes for 30+ years. I studied electrical engineering and computer science at U.C. Berkeley (Go Bears!) with the hope of applying my knowledge to diabetes technology. The significance of clinical practice became clear to me after my siblings also developed diabetes. I am devoting my life to advancing the care of diabetes in people of all ages.
-
Shoeb Lallani
Affiliate, Department Funds
Resident in NeurologyBioStanford Neurology Residency 2026 | Research in Schnitzer Lab | Interested in basal ganglia circuity and identification of molecular markers to serve as therapeutic targets for the treatment of movement disorders
-
Mable Lam
Postdoctoral Scholar, Neurosurgery
Current Research and Scholarly InterestsMyelin is required for rapid nerve signaling by insulating axons to accelerate action potential propagation. Myelin-forming cells of the central nervous system, called oligodendrocytes, orchestrate one of the most complex morphological transformations in neurobiology. Each oligodendrocyte can extend multiple processes that selectively wrap axons in tens to hundreds of spiraling membrane layers, forming myelin sheaths that vary in thickness and length. Furthermore, oligodendrocytes can respond to neural activity by adding new sheaths or by changing the geometry of pre-existing sheaths to tune neural circuitry, a process known as adaptive myelination.
What are the membrane trafficking mechanisms that drive adaptive myelination in oligodendrocytes?
How can these mechanisms be stimulated to promote myelin regeneration in disease?
By using transgenic mouse models and primary oligodendrocytes, we have found that SNARE-mediated exocytosis drives membrane addition in myelin sheaths. Current research is focused on how these pathways in oligodendrocytes may be regulated during adaptive myelination. -
Vinh Lam
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Vinh Lam is a Clinical Assistant Professor in the Department of Medicine, Division of Primary Care and Population health. He earned his MD from the David Geffen School of Medicine at UCLA and chose to stay in Los Angeles to complete his family medicine residency training at UCLA. During his training, Dr. Lam developed a strong interest in teaching and medical education through his involvement with resident education and the graduate medical education committee. He also spent 1 year as a resident informaticist where he also became very interested in informatics, medical technology, and innovative solutions to improving patient health outcomes and decreasing physician burnout. Dr. Lam enjoys caring for patients of all ages from pediatrics to geriatrics, performing office-based procedures, and prioritizing preventative care.
Outside of medicine, Dr. Lam loves to travel with his family, dabbles in photography and videography, and enjoys attempting to recreate meals he has had while traveling with his wife. -
Tracy Lam-Hine
Postdoctoral Scholar, Epidemiology
BioTracy Lam-Hine (he/him), DrPH, MBA, is a postdoctoral research fellow mentored by Dr. David Rehkopf in the Stanford Medicine Department of Epidemiology and Population Health and the Stanford Center for Population Health Sciences. His research focuses on improving the measurement of structural racism in epidemiologic studies, the cardiopulmonary and mental health of Multiracial people in the United States, and the application of methods in social epidemiology to racial health inequities. Dr. Lam-Hine also collaborates with state and local health jurisdictions in California and Hawaii in applied epidemiology and surveillance projects on topics including structural racism, adolescent health, and COVID-19.
-
Emmet Lamb
Professor of Gynecology and Obstetrics, Emeritus
BioSee Curriculum Vitae
-
Scott R. Lambert, MD
Professor of Ophthalmology and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsMy research has focused on improving the visual outcomes of children with congenital cataracts. I organized a randomized clinical trial, the Infant Aphakia Treatment Study to compare the visual outcomes of infants optically corrected with a contact lens vs. an intraocular lens after unilateral cataract surgery. A second area of research has been ocular growth after cataract surgery.
-
Max Lamparth
Postdoctoral Scholar, Infectious Diseases
BioMax is a postdoctoral fellow at the Center for International Security and Cooperation, the Stanford Center for AI Safety, and the Stanford Existential Risks Initiative at Stanford University. I am advised by Prof. Clark Barrett, Prof. Steve Luby, and Prof. Paul Edwards.
With his research, he wants to make AI systems more secure and safe to use. Specifically, he is focussing on how to improve the robustness and alignment of language models, how to make their inner workings more interpretable, and how to reduce the potential for misuses.
He received his Ph.D. in August 2023 from the Physics Department at the Technical University of Munich and previously a B.Sc. and M.Sc. from the Ruprecht Karl University of Heidelberg. -
Linda (Yu-Ling) Lan
Postdoctoral Scholar, Genetics
BioLinda Lan, DVM, PhD is a postdoctoral fellow in the Snyder Lab. Her research focuses on understanding long-term illness post-acute infections by using a combination of different types of data (multi-omics) and wearable technologies. Currently, Linda is working on three projects.
The first project involves studying the shared mechanisms of long COVID, ME/CFS, and PTLDS using smartwatches and micro-sampling. The second project involves examining the role of autoantibodies in long COVID patients and COVID vaccine side effects. The third project involves exploring the changes in the molecular and physiological responses of astronauts during short space flights using multi-omics and wearable devices.
Linda previously conducted her PhD research at the University of Chicago, where she studied memory B cell responses to a chimeric-based universal influenza virus vaccine candidate. In her leisure time, she enjoys running, hiking, and listening to audiobooks. -
Samuel Lancaster
Scientific Director of the Metabolic Health Center, Genetics
BioScientific Director, Metabolic Health Center, Stanford University School of Medicine
-
Lukas D. Landegger
Instructor, Otolaryngology (Head and Neck Surgery)
BioDr. Landegger is a clinician-scientist (otolaryngologist-head and neck surgeon) and Instructor at Stanford University School of Medicine. After gaining clinical as well as research experience in various countries (US, UK, France, Spain, Germany, Singapore, Australia), he specialized in otology with translational hearing research in Vienna, Austria and for five years in Boston (Mass Eye and Ear, Harvard Medical School), leading to a PhD in Neuroscience. Apart from clinical projects, current basic research foci are funded by a grant obtained from the American Society of Gene & Cell Therapy and include inner ear gene therapy, vestibular schwannoma, noise-induced hearing loss, and others.
-
Matthew Landry
Member, Maternal & Child Health Research Institute (MCHRI)
BioCurrent research focuses on identifying the optimal diet (or diets) for chronic disease prevention and addressing the challenges of designing, implementing and reporting clinical trials that test dietary patterns. Particularly interested behavioral interventions that promote plant-forward and plant-based diets. Passionate advocator for policies that address nutrition-related health inequalities particularly in low resource settings and/or with communities experiencing health inequalities related to food insecurity and structural disparities.
Assistant Professor of Population Health and Disease Prevention at University of California, Irvine (effective July 1, 2023) -
Alfred Lane
Professor of Dermatology and of Pediatrics at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsDeveloping gene therapy for genetic skin diseases is my major focus. Prior to that, we are developing methods to give effective and efficient care to infants with rare and disabling genetic skin diseases including epidermolysis bullosa and ichthyosis as well as infants and children with unusual and difficult to manage vascular malformations. I am also interested in clinical studies within the NICU protecting premature infants skin and clinical studies in children with common skin diseases.
-
Barton Lane
Professor of Radiology (Diagnostic Radiology) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsAs a professor in the Medical Center Line, my primary investigative interest has been in clinical neuroradiology. This encompasses spinal cord and spine disease, degenerative and demyelinating diseases of the central nervous system, strokes and infarction, and chronic epilepsy syndromes. Facial and head and neck vascular malformations and hemangiomas have been a focus of interest for many years, with collaborative projects involving dermatology and functional restoration services.
-
Michael Lange
Affiliate, Department Funds
BioUndergrad: Brigham Young University
Medical School: Indiana University School of Medicine
Medical Internship: General Surgery, Stanford Health Care -
Jamison Langguth
Clinical Research Manager, IMA, Med/Stanford Center for Clinical Research
Bio2020 Fellowship, Life Science Entrepreneurship (Blavatnik), Yale University
2018 MPH, Health Management, Harvard University
2015 MSED, Education Policy, University of Pennsylvania
2010 BS, Psychology, Drexel University -
Curtis Langlotz
Professor of Radiology (Thoracic Imaging), of Medicine (Biomedical Informatics Research), of Biomedical Data Science and Senior Fellow at the Stanford Institute for HAI
Current Research and Scholarly InterestsI am interested in the use of deep neural networks and other machine learning technologies to help radiologists detect disease and eliminate diagnostic errors. My laboratory is developing deep neural networks that detect and classify disease on medical images. We also develop natural language processing methods that use the narrative radiology report to create large annotated image training sets for supervised machine learning experiments.
-
Marvin Langston
Assistant Professor of Epidemiology and Population Health
BioDr. Marvin Langston is an Assistant Professor of Epidemiology and Population Health. He is a member of the Stanford Cancer Institute and Urologic Cancer Epidemiology Lab. He is an epidemiologist by training who focuses on the fields of benign prostate and pelvic conditions and urological cancers including prostate and kidney cancers.
Prior to Stanford, he served as a Research Scientist in the Division of Research at Kaiser Permanente Northern California. Dr. Langston received his PhD in Epidemiology from the University of Arizona’s College of Public Health followed by postdoctoral training in Cancer Prevention and Control at Washington University in Saint Louis School of Medicine.
His program of research intends to characterize and measure infectious agents, environmental toxicants, and lifestyle factors; to evaluate the role of these factors in urological cancer etiology and outcomes; and to identify populations at high risk of exposure to these factors. So far he has focused this research to address the following questions: 1) What role do sexually transmitted infections and other systemic infections have in prostate damage and ensuing prostate cancer risk? 2) How can we appropriately model and define early life risk factors for urological cancers? 3) Can we harmonize molecular and clinical aspects of urological condition diagnoses to produce well characterized outcomes for biomarker discovery and etiological investigation? He has primarily addressed these questions using a variety of molecular and clinical epidemiology approaches while developing expertise in the cross-cutting theme of cancer health disparities with particular interests in the cancer care experiences of sexual and gender minorities and racial/ethnic minorities.
Dr. Langston has been studying the impact of exogenous factors on prostate specific antigen (PSA) concentration in young men as a marker of prostate damage and inflammation for over a decade. As early life PSA has been found predictive of future prostate cancer mortality, he has now setout to optimize risk-stratified screening for prostate cancer. This promising approach uses men’s baseline PSA values to inform their risk of future aggressive and/or fatal prostate cancer and determine their frequency of further screening. Under this approach, men with high baseline age-specific total PSA levels receive more frequent screening and men with lower levels receive less frequent screening. Dr. Langston was awarded an R01 from NCI to evaluate this approach using historically collected biospecimen. His funded research trajectory to this point also includes four training awards (2-NCI and 2-NIDDK) and several internal grants. Dr. Langston was selected in the inaugural class of the White House Cancer Moonshot Scholars for his work. -
Benjamin Laniakea
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Benji Laniakea serves as the chief of the Stanford LGBTQ+ Adult Clinical Program, which offers comprehensive and tailored healthcare for the LGBTQ+ patient population for patients of all ages, sexualities, and gender identities. They also serve as the theme lead for the Sex, Gender, Sexuality, and Sexual Function curriculum at the Stanford School of Medicine for which they received the Arthur L. Bloomfield Award, and have the honor of advising the American Medical Association on LGBTQ+ Health.
-
Maarten Lansberg, MD, PhD
Professor of Neurology (Adult Neurology) and, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsMy research involves the design and conduct of clinical trials to discover new treatments for patients who have suffered a stroke. These trials span treatment of acute stroke, stroke recovery, and stroke prevention. My research in acute stroke is primarily focused on the use of advanced neuroimaging methods (CT and MRI) to select patients who are most likely to benefit from therapies aimed at restoring blood flow to the brain in patients who have suffered a stroke.
-
Tobias Lanz
Assistant Professor of Medicine (Immunology and Rheumatology)
BioTobias Lanz, MD is an Assistant Professor at the Institute for Immunity, Transplantation, and Infection and the Division of Immunology and Rheumatology at Stanford. His research focuses on B cell biology in neuroimmunological diseases and rheumatic diseases with neurological manifestations. He uses high-throughput screening technologies, and methods from structural and cell biology to identify new autoantigens and to understand how certain self-reactive B cells escape tolerance mechanisms. He is particularly interested in molecular mechanisms that explain the association between Epstein Barr Virus (EBV) and autoimmunity.
Tobias went to medical school at the Eberhard Karls University in Tübingen, Germany and at the University College of London. He wrote his MD thesis at Dr. Michael Platten's laboratory at the Hertie Institute for Clinical Brain Research in Tübingen, Germany before joining Dr. Lawrence Steinman’s neuroimmunological laboratory at Stanford as a research scholar. After medical school he pursued his scientific and clinical training at the German Cancer Research Center (DKFZ) and the Department of Neurology at the University Hospital in Heidelberg, Germany. In 2015 he joined Dr. William Robinson’s lab at Stanford, where he investigated environmental triggers of autoimmunity, including viruses and milk consumption. In his most recent work, he characterized the B cell repertoire in the spinal fluid of patients with multiple sclerosis (MS) and identified molecular mimicry between EBV EBNA1 and the glial cellular adhesion molecule GlialCAM as a driver of neuroinflammation (Lanz et al., Nature, 2022). His long term objective is to leverage these newly discovered mechanistic insights to develop next-generation biomarkers and therapeutics for autoimmune diseases. -
Bryan Lanzman, MD
Clinical Assistant Professor, Radiology
BioDr. Bryan Lanzman completed his medical degree and radiology residency at Columbia University Medical Center, before coming to Stanford University for a 2-year Neuroradiology fellowship. He joined the faculty at Stanford in 2017 and is actively involved in medical student and resident education, as well as quality improvement efforts within the neuroradiology section. He also serves as a co-director of the Neuroradiology clerkship for medical students, and for the Neuroradiology elective for neurology residents.
